1. Home
  2. IQV vs FIG Comparison

IQV vs FIG Comparison

Compare IQV & FIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • FIG
  • Stock Information
  • Founded
  • IQV 1982
  • FIG 2012
  • Country
  • IQV United States
  • FIG United States
  • Employees
  • IQV N/A
  • FIG N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • FIG Computer Software: Prepackaged Software
  • Sector
  • IQV Health Care
  • FIG Technology
  • Exchange
  • IQV Nasdaq
  • FIG Nasdaq
  • Market Cap
  • IQV 31.0B
  • FIG 34.1B
  • IPO Year
  • IQV 2013
  • FIG 2025
  • Fundamental
  • Price
  • IQV $200.67
  • FIG $71.41
  • Analyst Decision
  • IQV Strong Buy
  • FIG Hold
  • Analyst Count
  • IQV 20
  • FIG 9
  • Target Price
  • IQV $232.90
  • FIG $69.71
  • AVG Volume (30 Days)
  • IQV 1.3M
  • FIG 11.7M
  • Earning Date
  • IQV 10-28-2025
  • FIG 09-03-2025
  • Dividend Yield
  • IQV N/A
  • FIG N/A
  • EPS Growth
  • IQV N/A
  • FIG N/A
  • EPS
  • IQV 6.92
  • FIG 0.48
  • Revenue
  • IQV $15,700,000,000.00
  • FIG $893,423,000.00
  • Revenue This Year
  • IQV $5.99
  • FIG $37.25
  • Revenue Next Year
  • IQV $4.95
  • FIG $21.50
  • P/E Ratio
  • IQV $28.98
  • FIG $148.09
  • Revenue Growth
  • IQV 3.60
  • FIG 48.36
  • 52 Week Low
  • IQV $134.65
  • FIG $49.53
  • 52 Week High
  • IQV $237.34
  • FIG $142.92
  • Technical
  • Relative Strength Index (RSI)
  • IQV 58.50
  • FIG N/A
  • Support Level
  • IQV $176.16
  • FIG N/A
  • Resistance Level
  • IQV $208.00
  • FIG N/A
  • Average True Range (ATR)
  • IQV 5.85
  • FIG 0.00
  • MACD
  • IQV 1.65
  • FIG 0.00
  • Stochastic Oscillator
  • IQV 68.54
  • FIG 0.00

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About FIG Figma Inc.

Figma Inc is engaged in transforming ideas into digital products and experiences. The group focuses on the entire software creation lifecycle, enabling it to quickly launch new products on Figma's browser-based platform and reinforcing its belief that design extends well beyond a single step or role. The company adopts an expansive view, as design is more than how something looks, feels, or works. It derives its revenue from sales of subscriptions for access to its platform.

Share on Social Networks: